RYCCX
Price
$395.84
Change
-$30.81 (-7.22%)
Updated
Dec 18 closing price
RYMKX
Price
$56.37
Change
-$4.00 (-6.63%)
Updated
Dec 18 closing price
Ad is loading...

RYCCX vs RYMKX

Header iconRYCCX vs RYMKX Comparison
Open Charts RYCCX vs RYMKXBanner chart's image
Rydex NASDAQ-100® 2x Strategy C
Price$395.84
Change-$30.81 (-7.22%)
VolumeN/A
CapitalizationN/A
Rydex Russell 2000 1.5x Strategy H
Price$56.37
Change-$4.00 (-6.63%)
VolumeN/A
CapitalizationN/A
RYCCX vs RYMKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYCCX vs. RYMKX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCCX is a Buy and RYMKX is a Hold.

FUNDAMENTALS
Fundamentals
RYCCX has more cash in the bank: 1.53B vs. RYMKX (8.15M). RYMKX pays higher dividends than RYCCX: RYMKX (0.19) vs RYCCX (0.00). RYCCX was incepted earlier than RYMKX: RYCCX (24 years) vs RYMKX (24 years). RYCCX is a more actively managed with annual turnover of: 461.00 vs. RYMKX (9.00). RYCCX (2500) and RYMKX (2500) have matching initial minimum investment requirements. RYCCX annual gain was more profitable for investors over the last year : 45.37 vs. RYMKX (23.05). RYCCX return over 5 years is better than : 189.14 vs. RYMKX (-12.98).
RYCCXRYMKXRYCCX / RYMKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years24 years-
Gain YTD44.12419.072231%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.53B8.15M18,824%
Annual Yield % from dividends0.000.19-
Returns for 1 year45.3723.05197%
Returns for 3 years28.830.2511,493%
Returns for 5 years189.14-12.98-1,457%
Returns for 10 years585.5113.524,332%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NILTX13.82N/A
N/A
Neuberger Berman International Sel Tr
BHSRX61.42N/A
N/A
BlackRock Health Sciences Opps R
BGGSX28.57N/A
N/A
Baillie Gifford US Equity Growth I
PRSRX53.17-0.30
-0.56%
Putnam Research R
PMDHX19.40-0.23
-1.17%
Principal Small-MidCap Dividend Inc R6